In a nutshell
This study compared the effects on heart disease for SGLT2 inhibitors vs DPP-4 inhibitors in patients with type 2 diabetes (T2D). It found that patients using SGLT2 inhibitor medications had lower rates of heart failure, heart attack, and stroke.
T2D is a disorder of high levels of glucose (sugar) in the blood. T2D is connected to obesity and changes in…